Abstracts tagged "Confounding"

Abstract Number: 1082 • 2014 ACR/ARHP Annual Meeting
Risk of Intra Cranial Hemorrhage among Patients with Anti-Phospho-Lipid-Antibody (aPL) syndrome vs Systemic Lupus Erythematosus (SLE) in Stroke Population: A Nationwide Analysis
Tapan Mehta¹, Khushboo Sheth², Ronak Soni³, Sonam Puri² and Kathan Mehta⁴, ¹Neurology, University of Connecticut, Farmington, CT, Farmington, CT, ²Internal Medicine, University of Connecticut, Farmington, CT, Farmington, CT, ³Internal Medicine, Government Medical College, Surat, India, ⁴Internal Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, Pittsburgh, PA
Background/Purpose Central nervous system involvement is common in Systemic Lupus Erythematosus (SLE) and was first described in 1873. Though ischemic involvement is more common than…
Abstract Number: 1081 • 2014 ACR/ARHP Annual Meeting
Prediction of Mortality Risk Related to Cerebrovascular Accidents in Patients with Systemic Lupus Erythematosus (SLE) vs Anti-Phospho-Lipid-Antibody (aPL) syndrome
Khushboo Sheth¹, Tapan Mehta², Sonam Puri¹, Ronak Soni³ and Kathan Mehta⁴, ¹Internal Medicine, University of Connecticut, Farmington, CT, Farmington, CT, ²Neurology, University of Connecticut, Farmington, CT, Farmington, CT, ³Internal Medicine, Government Medical College, Surat, India, ⁴Internal Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, Pittsburgh, PA
Background/Purpose : It is well-established that patients with co-existent Systemic Lupus Erythematosus (SLE) and Anti-Phospho-Lipid-Antibody (aPL) syndrome are at increased risk of cerebrovascular accidents (CVA).…
Abstract Number: 2357 • 2013 ACR/ARHP Annual Meeting
Confounding By Indication Distorts The Relationship Between Steroid Use and Cardiovascular Disease In Rheumatoid Arthritis
Alper M. van Sijl¹, Maarten Boers², Alexandre E. Voskuyl¹ and Mike T. Nurmohamed¹, ¹Rheumatology, VU University Medical Center, Amsterdam, Netherlands, ²Epidemiology & Biostatistics, VU University Medical Center, Amsterdam, Netherlands
Background/Purpose: Glucocorticoids (GC) are among the most effective drugs in rheumatoid arthritis (RA), but concerns over long-term side effects have not been resolved. Recent studies…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].